http://orcid.org/0000-0002-7760-246X
References
- Furusawa J, Oridate N, Suzuki F, et al. Initial CT findings in early tongue and oral floor cancer as predictors of late neck metastasis. Oral Oncol. 2008;44:793–797.
- Chone CT, Magalhes RS, Etchehebere E, et al. Predictive value of sentinel node biopsy in head and neck cancer. Acta Otolaryngol. 2008;128:920–924.
- Sharma P, Shah SV, Taneja C, et al. A prospective study of prognostic factors for recurrence in early oral tongue cancer. J Clin Diagn Res. 2013;7:2559–2562.
- Simpson MA. Systemic blockade of the hyaluronan receptor for endocytosis prevents lymph node metastasis of prostate cancer. Int J Cancer. 2012;131:E836–E840.
- Toole BP, Hascall VC. Hyaluronan and tumor growth. Am J Pathol. 2002;161:745–747.
- Lindquist D, Ahrlund-Richter A, Tarjan M, et al. Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res. 2012;32:153–161.
- Riesterer O, Milas L, Ang KK. Combining molecular therapeutics with radiotherapy for head and neck cancer. J Surg Oncol. 2008;97:708–711.
- Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129–2139.
- Bourguignon LY, Earle C, Wong G, et al. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene. 2012;31:149–160.
- Zackrisson B, Kjellén E, Söderström K, et al. Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma – the ARTSCAN trial. Radiother Oncol. 2015;117:99–105.
- Jonsson EL, Nylander K, Hallén L, et al. Effect of radiotherapy on expression of hyaluronan and EGFR and presence of mast cells in squamous cell carcinoma of the head and neck. Oncol Lett. 2012;4:1177.
- Kersemaekers AM, Fleuren GJ, Kenter GG, et al. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res. 1999;5:577–586.
- Ryott M, Wangsa D, Heselmeyer-Haddad K, et al. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. Eur J Cancer. 2009;45:1700–1708.
- Mehta A, Chowdhary M, Sinha R. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma. J Oral Pathol Med. 2015;44:818–822.
- Theocharis S, Giaginis C, Dana E, et al. Phosphorylated epidermal growth factor receptor expression is associated with clinicopathologic parameters and patient survival in mobile tongue squamous cell carcinoma. J Oral Maxillofac Surg. 2017;75:632–640.
- Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer. 2005;103:1843–1849.
- Dahlgren L, Dahlstrand HM, Lindquist D, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004;112:1015–1019.
- Govers TM, Hannink G, Merkx MA, et al. Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis. Oral Oncol. 2013;49:726–732.
- Mitani S, Tomioka T, Hayashi R, et al. Anatomic invasive depth predicts delayed cervical lymph node metastasis of tongue squamous cell carcinoma. Am J Surg Pathol. 2016;40:934–942.
- Okamoto M, Nishimine M, Kishi M, et al. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med. 2002;31:227–233.
- Zhang LL. Oral tongue cancer patients show a better overall survival than base of tongue cancer patients. J Cancer Res Clin Oncol. 2012;138:341–346.
- Hammarstedt L, Lu Y, Marklund L, et al. Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden. Oral Oncol. 2011;47:636–641.